INTRODUCTION: Intracerebral hemorrhage (ICH) is a devastating form of stroke commonly resulting in severe morbidity and high mortality. Secondary brain injury often occurs in the days following the initial hemorrhage and is associated with significant neurological deterioration. The neurochemistry associated with secondary injury is poorly understood. The purpose of this study is to characterize the neurochemical changes in perihematomal tissue during frameless minimally invasive evacuation of spontaneous hematomas. METHODS: This is a nonrandomized prospective microdialysis study of 12 consecutive patients undergoing Frameless Stereotactic Aspiration and Thrombolysis (FAST) of deep ICHs. Hourly glucose, lactate, pyruvate, and glutamate were measured in the perihematomal tissue of patients undergoing minimally invasive hematoma evacuation. Analyte concentrations were compared to evaluate the natural history of perihematomal neurochemistry and to identify changes potentially related to secondary injury. RESULTS: Brain hematoma volumes were reduced 87% during FAST and National Institute of Health Stroke Scale (NIHSS) scores were improved from an average of 19 at admission to 12.6 at time of discharge from the intensive care unit. Glutamate average values decreased from the first 24 hours of measurement (12 mmol/L +/- 6) to the final 24-hour epoch (5 mmol/L +/- 6). Glutamate reduction showed a significant linear (p = 0.0007) and quadratic (p <0.05) trend during hematoma drainage. Lactate pyruvate ratios (LPR), a common marker of ischemia, were unchanged. CONCLUSIONS: This study reports that elevated levels of glutamate are found in the perihematomal region after ICH and are decreased during hematoma drainage. Conversely, ischemic LPRs are not found in perihematomal regions and were unchanged during hematoma drainage. These data suggest that excitotoxicity related to glutamate may have an important impact on secondary injury. The data failed to support the role of ischemia in secondary perihematomal damage.
INTRODUCTION:Intracerebral hemorrhage (ICH) is a devastating form of stroke commonly resulting in severe morbidity and high mortality. Secondary brain injury often occurs in the days following the initial hemorrhage and is associated with significant neurological deterioration. The neurochemistry associated with secondary injury is poorly understood. The purpose of this study is to characterize the neurochemical changes in perihematomal tissue during frameless minimally invasive evacuation of spontaneous hematomas. METHODS: This is a nonrandomized prospective microdialysis study of 12 consecutive patients undergoing Frameless Stereotactic Aspiration and Thrombolysis (FAST) of deep ICHs. Hourly glucose, lactate, pyruvate, and glutamate were measured in the perihematomal tissue of patients undergoing minimally invasive hematoma evacuation. Analyte concentrations were compared to evaluate the natural history of perihematomal neurochemistry and to identify changes potentially related to secondary injury. RESULTS:Brain hematoma volumes were reduced 87% during FAST and National Institute of Health Stroke Scale (NIHSS) scores were improved from an average of 19 at admission to 12.6 at time of discharge from the intensive care unit. Glutamate average values decreased from the first 24 hours of measurement (12 mmol/L +/- 6) to the final 24-hour epoch (5 mmol/L +/- 6). Glutamate reduction showed a significant linear (p = 0.0007) and quadratic (p <0.05) trend during hematoma drainage. Lactate pyruvate ratios (LPR), a common marker of ischemia, were unchanged. CONCLUSIONS: This study reports that elevated levels of glutamate are found in the perihematomal region after ICH and are decreased during hematoma drainage. Conversely, ischemicLPRs are not found in perihematomal regions and were unchanged during hematoma drainage. These data suggest that excitotoxicity related to glutamate may have an important impact on secondary injury. The data failed to support the role of ischemia in secondary perihematomal damage.
Authors: Paul Vespa; Marvin Bergsneider; Nayoa Hattori; Hsiao-Ming Wu; Sung-Cheng Huang; Neil A Martin; Thomas C Glenn; David L McArthur; David A Hovda Journal: J Cereb Blood Flow Metab Date: 2005-06 Impact factor: 6.200
Authors: C Sills; C Villar-Cordova; W Pasteur; A Ramirez; L Lamki; B Barron; N Mullani; J Grotta Journal: J Stroke Cerebrovasc Dis Date: 1996 Sep-Oct Impact factor: 2.136
Authors: Maged D Fam; Daniel Hanley; Agnieszka Stadnik; Hussein A Zeineddine; Romuald Girard; Michael Jesselson; Ying Cao; Lynn Money; Nichol McBee; Amanda J Bistran-Hall; W Andrew Mould; Karen Lane; Paul J Camarata; Mario Zuccarello; Issam A Awad Journal: Neurosurgery Date: 2017-11-01 Impact factor: 4.654
Authors: Tim Lekic; Richard Hartman; Hugo Rojas; Anatol Manaenko; Wanqiu Chen; Robert Ayer; Jiping Tang; John H Zhang Journal: J Neurotrauma Date: 2010-03 Impact factor: 5.269
Authors: Jana Portnow; Behnam Badie; Xueli Liu; Paul Frankel; Shu Mi; Mike Chen; Timothy W Synold Journal: J Neurooncol Date: 2014-03-15 Impact factor: 4.130
Authors: Paul Vespa; Daniel Hanley; Joshua Betz; Alan Hoffer; Johnathan Engh; Robert Carter; Peter Nakaji; Chris Ogilvy; Jack Jallo; Warren Selman; Amanda Bistran-Hall; Karen Lane; Nichol McBee; Jeffery Saver; Richard E Thompson; Neil Martin Journal: Stroke Date: 2016-10-06 Impact factor: 7.914
Authors: Jennifer Diedler; Marek Sykora; Philipp Hahn; Kristin Heerlein; Marion N Schölzke; Lars Kellert; Julian Bösel; Sven Poli; Thorsten Steiner Journal: Crit Care Date: 2010-04-14 Impact factor: 9.097
Authors: S Thomas Carmichael; Paul M Vespa; Jeffery L Saver; Giovanni Coppola; Daniel H Geschwind; Sidney Starkman; Chad M Miller; Chelsea S Kidwell; David S Liebeskind; Neil A Martin Journal: J Cereb Blood Flow Metab Date: 2008-07-16 Impact factor: 6.200
Authors: Chad M Miller; Paul Vespa; Jeffrey L Saver; Chelsea S Kidwell; Stanley T Carmichael; Jeffry Alger; John Frazee; Sid Starkman; David Liebeskind; Valeriy Nenov; Robert Elashoff; Neil Martin Journal: Surg Neurol Date: 2008-05